GLYCODIAG
Desconocido
AUREUS: wAll teichoic acids as immUnogenic and conseRved altErnative targets for therapies versUs S. aureus
The AUREUS doctoral network meets the increasing need of a highly qualified work force to counteract multidrug-resistant S. aureus infection...
2024-07-01 - 2029-01-31 | Financiado
2024-07-01 - 2029-01-31 | Financiado
synBIOcarb: Synthetic biology of carbohydrate binding proteins engineering protein carbohydrate interactions fo...
GLYCODIAG
participó en un
H2020:
H2020-MSCA-ITN-2018
The aim of the Initial Training Network will be to train 15 early stage researchers in the emerging field of synthetic glycobiology, equippi...
2018-08-20 - 2023-03-31 | Financiado
2018-08-20 - 2023-03-31 | Financiado
IMMUNOSHAPE: Development of Selective Carbohydrate Immunomodulators Targeting C type Lectin Receptors on Antigen...
GLYCODIAG
participó en un
H2020:
H2020-MSCA-ITN-2014
IMMUNOSHAPE aims at training a new generation of scientists that will be capable of combining state of the art synthesis and screening techn...
2014-12-12 - 2018-12-31 | Financiado
2014-12-12 - 2018-12-31 | Financiado
* No se disponen de datos de la empresa actual.